Navigation Links
Chem Rx Corporation Schedules Conference Call to Review Full Year 2007 Financial Results
Date:3/31/2008

LONG BEACH, N.Y., March 31 /PRNewswire-FirstCall/ -- Chem Rx Corporation (OTC Bulletin Board: PMQC; PMQCU; PMQCW), a leading provider of institutional pharmacy services, announced today that it will hold a conference call to review 2007 financial results and discuss 2008 outlook on April 1, 2008 at 8:30 a.m. EDT. Jerry Silva, Chairman and Chief Executive Officer and Steven C. Silva, President and Chief Operating Officer, will host the conference call. A press release announcing 2007 year-end results and 2008 guidance will be issued this evening.

To participate in the conference call, please dial 1-877-407-0784 (USA) or 1-201-689-8560 (international). In addition, a dial-up replay of the conference call will be available beginning April 1, 2008 at approximately 10:30 a.m. ET and will remain available until April 8, 2008. To access the replay, please dial 1-877-660-6853 (USA) or 1-201-612-7415 (international) and reference the account number 3055 and the access code 280675. A web cast of the call will also be available from the Investor Relations section on the corporate web site at http://www.chemrx.net through April 29, 2008.

About Chem Rx Corporation

Founded more than 40 years ago, Chem Rx Corporation is a leading provider of institutional pharmacy services in the New York City metropolitan area, as well as parts of New Jersey, upstate New York, and Pennsylvania. Chem Rx's client base includes skilled nursing facilities and a wide range of other long-term care facilities. Through its services, Chem Rx provides more than 65,000 institutional residents with prescription and non-prescription drugs, intravenous medications, durable medical equipment items and surgical supplies. Chem Rx's website address is http://www.chemrx.net.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are based upon the current beliefs and expectations of Chem Rx's management and are subject to risks and uncertainties that could cause actual results to differ from the forward-looking statements. The following factors, among others, could cause actual results to differ from those set forth in the forward-looking statements: compliance with government regulations; changes in legislation or regulatory environments; requirements or changes adversely affecting the health care industry, including changes in Medicare reimbursement policies; fluctuations in customer demand; management of rapid growth; intensity of competition; timing, approval and market acceptance of new product introductions and institutional pharmacy locations; general economic conditions; geopolitical events and regulatory changes, as well as other relevant risks detailed in Chem Rx's filings with the Securities and Exchange Commission. The information set forth herein should be read in light of such risks. Chem Rx Corporation does not assume any obligation to update the information contained in this press release.

Contacts: The Ruth Group

Steven C. Silva Investor Relations

President and Chief Operating Stephanie Carrington / Jared Hoffman

Officer (646) 536-7017 / 7013

Chem Rx Corporation scarrington@theruthgroup.com

516-889-8770 jhoffman@theruthgroup.com


'/>"/>
SOURCE Chem Rx Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Immunosyn Corporation Announces 2007 Results, Files 10KSB
2. Spectros Corporation Reports 2007 Year-Over-Year Sales Rise 36%
3. Lentigen Corporation Announces Exclusive Licensing Agreement With Case Western Reserve University to Develop Novel Stem-Cell Therapy for Brain Cancer
4. Oregon Health Care Quality Corporation Receives Important Designation from U.S. Department of Health and Human Services
5. Psychemedics Corporation Authorizes A 250,000 Share Stock Repurchase Program
6. Dr. Linda McAllister Joins Arbor Vita Corporation as Vice President of Diagnostics
7. Webcast Alert: Neogen Corporation Announces 3rd Quarter Results
8. USANAs CEO Myron W. Wentz, Ph.D. Has Been Elected to Serve on Immunosyn Corporations Board of Directors
9. Volcano Corporation Presentation at Cowen Healthcare Conference to be Webcast
10. Somanetics Corporation to Present at Cowen & Company 28th Annual Health Care Conference
11. MannKind Corporation Response to Recent Market Events
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 27, 2016 , ... Cancer experts from Austria, Hungary, Switzerland, ... a new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma has just ... now. , Biomarkers are components in the blood, tissue or body fluids ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... While ... machines such as the Cary 5000 and the 6000i models are higher end machines ... is the height of the spectrophotometer’s light beam from the bottom of the cuvette ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
Breaking Biology Technology:
(Date:3/23/2016)... WAKEFIELD, Massachusetts , March 23, 2016 ... kombiniert im Interesse erhöhter Sicherheit Gesichts- und ... Xura, Inc. (NASDAQ: MESG ... heute bekannt, dass das Unternehmen mit SpeechPro ... insbesondere aus der Finanzdienstleistungsbranche, wird die Möglichkeit ...
(Date:3/22/2016)... PROVO and SANDY, Utah ... Ontario (NSO), which operates the highest sample volume laboratory ... and Tute Genomics and UNIConnect, leaders in clinical sequencing ... announced the launch of a project to establish the ... panel. NSO has been contracted by ...
(Date:3/18/2016)... LONDON , March 18, 2016 ... Established Suppliers of Biometrics, ICT, Manned & Unmanned Vehicles, Physical ... & security companies in the border security market and ... and Europe has led ... your companies improved success. --> defence & ...
Breaking Biology News(10 mins):